Pancreas Adenocarcinoma Clinical Trials in Boston, Massachusetts
2 recruitingBoston, Massachusetts
Showing 1–2 of 2 trials
Recruiting
Phase 1
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Triple-Negative Breast CancerColorectal, CancerBiliary Tract Cancer+8 more
Zumutor Biologics Inc.100 enrolled3 locationsNCT06451497
Recruiting
Not Applicable
Genetic Testing Decision Aid
Epithelial Ovarian CarcinomaPancreas Adenocarcinoma
Massachusetts General Hospital350 enrolled2 locationsNCT05470920